Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

WHI-D12 is a potent and selective inhibitor of Bruton's tyrosine kinase

Nov. 26, 1999

Abbott's new LHRH antagonists, pharmaceutical compositions and use

Nov. 26, 1999

Novel antitumor agents for both leukemias and solid tumors discovered by Taiwanese scientists

Nov. 26, 1999

Xenova's IND for multidrug resistance modulator gets FDA approval

Nov. 26, 1999

AACR-NCI-EORTC news: Japanese research team presents new hypoxic cell radiosensitizing agent

Nov. 25, 1999

Mount Sinai investigators describe novel apoptosis-inducing agent at scientific forum

Nov. 25, 1999

BASF discloses protein kinase inhibitors useful as antiangiogenic agents

Nov. 25, 1999

Calcium entry blockers with potential in the treatment of prostate cancer

Nov. 25, 1999

Valentis initiates phase IIa trial of IFN-alpha gene medicine in angiosarcoma

Nov. 25, 1999

Combination therapy containing GTI-2040 shows remarkable antitumor activity

Nov. 25, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...